resiniferatoxin

09/01/2000 - "No statistically significant improvement in mean pain score was observed in placebo group 2. During resiniferatoxin infusion 4 group 1 patients noticed a light warm or burning sensation at the suprapubic and/or urethral level. "
08/01/1997 - "In particular, resiniferatoxin is only similar in potency for induction of pain but is much more effective for desensitization. "
01/01/2013 - "This review examines existing preclinical and clinical studies related to resiniferatoxin (RTX) and its potential uses in pain treatment. "
09/01/2000 - "We performed a randomized placebo controlled study with followup after 1 and 3 months using intravesical resiniferatoxin to treat hypersensitive disorder and bladder pain. "
01/01/2023 - "Resiniferatoxin causes nerve terminal depolarization block in the short term, which prevents pain during application and leading to nerve terminal desensitization/depletion in the long term resulting in long-lasting pain relief. "

09/01/2014 - "To evaluate the efficacy of resiniferatoxin in the treatment of patients with lifelong premature ejaculation. "
01/01/2017 - "Re: Resiniferatoxin for treatment of lifelong premature ejaculation: A preliminary study."
01/01/2017 - "Response to Re: Resiniferatoxin for treatment of lifelong premature ejaculation: A preliminary study."
09/01/2014 - "Response to Editorial Comment from Dr Sato to Resiniferatoxin for treatment of lifelong premature ejaculation: a preliminary study."
09/01/2014 - "Editorial Comment from Dr Sato to Resiniferatoxin for treatment of lifelong premature ejaculation: a preliminary study."

01/01/2020 - "Ultra-low doses of the transient receptor potential vanilloid 1 agonist, resiniferatoxin, prevents vomiting evoked by diverse emetogens in the least shrew (Cryptotis parva)."
05/10/2002 - "When ferrets were given resiniferatoxin (10 microg/kg, s.c.) 16 h prior to cisplatin, the emesis was still significantly inhibited. "
05/10/2002 - "In the ferret, resiniferatoxin (10 microg/kg, s.c.) 30 min prior to cisplatin completely inhibited acute emesis caused by cisplatin (10 mg/kg, i.p.). "
05/10/2002 - "When animals were given resiniferatoxin (10 microg/kg, s.c.) 24 h prior to cisplatin, the emesis was still inhibited, but not significantly. "
05/10/2002 - "In the dog, resiniferatoxin (10 microg/kg, s.c.) 30 min before the injection of cisplatin markedly prevented acute emesis induced by cisplatin. "

07/13/2010 - "To understand the effect of resiniferatoxin on neurogenic bladder by intravesical filling. "
07/13/2010 - "[Clinical study of resiniferatoxin on neurogenic bladder]."
08/01/2016 - "Resiniferatoxin (RTX) is used as experimental drug therapy for a range of neurogenic urinary bladder disorders. "
11/01/2015 - "Resiniferatoxin (RTX) is used as an experimental drug in therapy of neurogenic urinary bladder disorders. "
12/01/2001 - "Intravesical instillation of resiniferatoxin for neurogenic bladder dysfunction in a patient with myelodysplasia."

01/01/2012 - "In a recent study on the effects of PRF on resiniferatoxin-induced neuropathic pain in an animal model, the anti-allodynic effects of PRF were significantly greater when the PRF exposure duration was increased from 2 to 6 minutes. "
09/01/2012 - "The effect of epidural resiniferatoxin in the neuropathic pain rat model randomized trial: a complementary mechanism."
12/14/2022 - "Cutaneous Injection of Resiniferatoxin Completely Alleviates and Prevents Nerve-Injury-Induced Neuropathic Pain."
08/01/2019 - "We first injected resiniferatoxin (RTX) into Sprague Dawley rats to construct the neuralgia model. "
01/01/2017 - "Antiallodynic effect of intrathecal resiniferatoxin on neuropathic pain model of chronic constriction injury."